1. Storb R. “Marrow transplantation in the treatment of malignant diseases.” Progress in transplantation. Morris and Tilney ed. 1984 Churchill Livingstone. New York.
2. Kernan NA, Bartsch G, Ash R, Beatty PG, Champlin R, Filipovich A, Gajewski J, Hansen J, Henslee-Downey J, McCullough Jea. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. New England Journal of Medicine. 1993; 328: 593–602.
3. Bishop MR, Henslee-Downey PJ, Anderson JR, Romond EH, Marciniak E, Yankey R, Reeves M, Thompson JS. Long-term survival in advanced chronic myelogenous leukemia following bone marrow transplantation from haploidentical related donors. Bone Marrow Transplantation. 1996; 18: 747–753.
4. Fleming DR, Henslee-Downey PJ, Romond EH, Harder EJ, Marciniak E, Munn RK, Messino MJ, Macdonald JS, Bishop M, Rayens MK, Thompson JS. Allogeneic bone marrow transplantation with T cell-depleted partially matched related donors for advanced acute lymphoblastic leukemia in children and adults: a comparative matched cohort study. Bone Marrow Transplantation 1996; 17: 917–922.
5. Filipovich AH, Vallera DA, Youle RJ, Haake R, Blazar BR, Arthur D, Neville DM, N.K.C. R, McGlave P, Kersey JH. Graft-versus-host disease prevention in allogeneic bone marrow transplanation from histocompatible siblings. Transplantation 1987; 44: 62–69.